Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-04-29

Clinical Trial Update: Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating immunogenicity of different fast protective traveler vaccination schemes using an inactivated Tick-Borne Encephalitis whole-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated Tick-Borne Encephalitis Whole Virus Vaccine (Tick-borne encephalitis vaccine, inactivated whole-virus)

Snippet

Sponsor: Elisabethinen Hospital | Conditions: Tick Borne Encephalitis | Phase 2 | Status: UNKNOWN